Patent · US Expired

Bioequivalence test for iron-containing formulations

US7169359B2 · kind B2 · utility

8Cited by

3References

22Claims

0Family size

Assignee

Luitpold Pharmaceuticals, Inc. · US

Inventors

Mary Jane Helenek · Brookville, US
Ralf Lange · Krefeld, DE
Richard P. Lawrence · Southold, US

Key dates

Filing date	Nov 2, 2004
Grant date	Jan 30, 2007
Priority date	—
Expiry date	Nov 2, 2024

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/143333
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A rapid method for assessing the bioequivalence of iron in iron-supplement formulations, particularly iron-sucrose formulations is described, which is based upon the kinetics of reduction of iron (III) to iron (II) in a sample of the formulation. Quality control methods and associated kits also are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.